49.00
price down icon1.03%   -0.51
after-market Handel nachbörslich: 49.00
loading
Schlusskurs vom Vortag:
$49.51
Offen:
$49.39
24-Stunden-Volumen:
1.05M
Relative Volume:
1.28
Marktkapitalisierung:
$2.75B
Einnahmen:
$651.97M
Nettoeinkommen (Verlust:
$59.71M
KGV:
45.81
EPS:
1.0696
Netto-Cashflow:
$172.03M
1W Leistung:
+1.34%
1M Leistung:
+6.04%
6M Leistung:
+57.71%
1J Leistung:
+53.65%
1-Tages-Spanne:
Value
$48.27
$49.81
1-Wochen-Bereich:
Value
$47.27
$51.78
52-Wochen-Spanne:
Value
$29.16
$51.78

Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile

Name
Firmenname
Supernus Pharmaceuticals Inc
Name
Telefon
301-838-2500
Name
Adresse
9715 KEY WEST AVENUE, ROCKVILLE, MD
Name
Mitarbeiter
674
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
SUPN's Discussions on Twitter

Vergleichen Sie SUPN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
SUPN
Supernus Pharmaceuticals Inc
49.00 2.78B 651.97M 59.71M 172.03M 1.0696
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-30 Hochstufung Cantor Fitzgerald Neutral → Overweight
2025-02-19 Herabstufung Cantor Fitzgerald Overweight → Neutral
2025-01-06 Eingeleitet Cantor Fitzgerald Overweight
2024-09-11 Herabstufung Piper Sandler Overweight → Neutral
2023-01-03 Fortgesetzt Jefferies Buy
2021-12-01 Fortgesetzt Jefferies Buy
2021-04-13 Hochstufung Jefferies Hold → Buy
2020-06-16 Hochstufung Piper Sandler Neutral → Overweight
2020-06-15 Fortgesetzt Jefferies Hold
2019-11-08 Herabstufung Berenberg Buy → Hold
2019-11-07 Herabstufung Stifel Buy → Hold
2019-11-06 Herabstufung Jefferies Buy → Hold
2018-11-12 Bestätigt B. Riley FBR Buy
2018-01-18 Bestätigt B. Riley FBR, Inc. Buy
2017-12-28 Bestätigt B. Riley FBR, Inc. Buy
2017-12-04 Hochstufung Janney Neutral → Buy
2017-11-08 Hochstufung Stifel Hold → Buy
2017-10-19 Eingeleitet FBR & Co. Buy
2017-09-19 Herabstufung Stifel Buy → Hold
2017-07-17 Herabstufung Piper Jaffray Overweight → Neutral
2017-07-14 Eingeleitet Janney Neutral
2017-06-01 Hochstufung Piper Jaffray Neutral → Overweight
2016-07-18 Herabstufung Northland Capital Outperform → Market Perform
2016-07-18 Herabstufung Piper Jaffray Overweight → Neutral
2016-02-08 Hochstufung Jefferies Hold → Buy
2015-11-05 Bestätigt Northland Capital Outperform
2015-10-28 Eingeleitet Northland Capital Outperform
Alle ansehen

Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten

pulisher
09:15 AM

Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

09:15 AM
pulisher
Oct 09, 2025

Supernus Pharmaceuticals Inc. (SUPN) Stock Price | Live Quotes & Charts | NSD - StocksToTrade

Oct 09, 2025
pulisher
Oct 09, 2025

Supernus Pharmaceuticals Shares Rise After Piper Sandler Upgrade - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Supernus Pharmaceuticals: A Rising Pharma Contender? - StocksToTrade

Oct 09, 2025
pulisher
Oct 09, 2025

Supernus Pharmaceuticals (SUPN) Stock Is Up, What You Need To Know - TradingView

Oct 09, 2025
pulisher
Oct 09, 2025

SUPN: Piper Sandler Raises Price Target to $65 and Upgrades Rati - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Piper Sandler Upgrades Supernus Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $65 From $40 - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Can Supernus Pharmaceuticals Inc. stock attract ESG capital inflowsJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How Supernus Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 05:01:01 - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Supernus (SUPN) Receives Upgraded Rating Amid Promising Product Outlook - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

How to use Fibonacci retracement on Supernus Pharmaceuticals Inc.2025 Price Action Summary & Safe Entry Zone Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is now a turning point for Supernus Pharmaceuticals Inc.July 2025 Earnings & Real-Time Sentiment Analysis - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $49.66 - Markets Mojo

Oct 08, 2025
pulisher
Oct 06, 2025

Will Supernus Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Weekly Top Performers Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How geopolitical tensions affect Supernus Pharmaceuticals Inc. stockCPI Data & Comprehensive Market Scan Insights - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Supernus Pharmaceuticals Inc. stock could be next big winnerJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using R and stats models for Supernus Pharmaceuticals Inc. forecasting2025 Macro Impact & Reliable Volume Spike Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Supernus Pharmaceuticals Inc. stock poised for growthPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Supernus Pharmaceuticals Inc. stock cheap compared to fundamentalsAnalyst Upgrade & Daily Stock Trend Reports - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Wall Street Zen Downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) to Hold - Defense World

Oct 05, 2025
pulisher
Oct 03, 2025

Smart tools for monitoring Supernus Pharmaceuticals Inc.’s price actionQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Real time social sentiment graph for Supernus Pharmaceuticals Inc.Trade Volume Summary & Real-Time Buy Zone Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Supernus Pharmaceuticals, Inc. $SUPN Shares Purchased by GAMMA Investing LLC - Defense World

Oct 03, 2025
pulisher
Oct 03, 2025

What MACD signals say about Supernus Pharmaceuticals Inc.Market Volume Summary & Low Drawdown Momentum Trade Ideas - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Supernus Pharmaceuticals stock hits 52-week high at 48.47 USD - Investing.com India

Oct 02, 2025
pulisher
Oct 02, 2025

Supernus Pharmaceuticals stock hits 52-week high at 48.47 USD By Investing.com - Investing.com Australia

Oct 02, 2025
pulisher
Oct 02, 2025

Supernus Pharmaceuticals (SUPN): Is the Current Share Price a Fair Reflection of Its True Valuation? - Yahoo Finance

Oct 02, 2025
pulisher
Oct 01, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 18% CAGR over the last five years - simplywall.st

Oct 01, 2025
pulisher
Oct 01, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Given New $63.00 Price Target at Cantor Fitzgerald - Defense World

Oct 01, 2025
pulisher
Sep 30, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $48.00 - Markets Mojo

Sep 30, 2025
pulisher
Sep 30, 2025

SUPN: Cantor Fitzgerald Increases Price Target to $63, Maintains Overweight Rating | SUPN Stock News - GuruFocus

Sep 30, 2025

Finanzdaten der Supernus Pharmaceuticals Inc-Aktie (SUPN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Kapitalisierung:     |  Volumen (24h):